Skip to main content
News Icon

Europe is a top destination for many researchers

ImmunoSensation2 Scientist, Dr. Bernardo Franklin was feature in a Nature article entitled "Europe is a top destination for many researchers". The article interviewed scientists from different parts of the world who are working in the EU.

“Science is not a recognized profession in Brazil, where I come from,” says Bernardo Franklin, an immunologist at the University of Bonn in Germany. “In Germany, PhD students are given working contracts, with regulations that provide them with insurances, pension and other benefits, and protect them from exploitation and abusive supervisors.”

Publication

https://www.nature.com/articles/d41586-019-01570-3

Related news

News Icon

Publication

B cells maintain antigen presentation in the splenic marginal zone

—A team of international researchers, including ImmunoSensation³ members Prof. Niels Lemmermann and Prof. Andreas Schlitzer, shows that B cells support antiviral CD8⁺ T-cell responses beyond antibody production. In a murine CMV model, B-cell deficiency weakened virus-specific CD8⁺ T-cell responses. Mechanistically, B-cell-derived lymphotoxin β maintained CD169⁺ macrophages and Langerin⁺ cDC1 cells in the splenic marginal zone, enabling efficient T-cell priming. The study was published in Cellular & Molecular Immunology.
Full publication
Zwei Personen: Links Prof. Pröpstl und rechts Prof. Boztug

Honors & Funding

University of Bonn and University Hospital Bonn strengthen early-career clinical scientists

—The Faculty of Medicine at the University of Bonn and the University Hospital Bonn (UKB) are jointly launching the EKFS doctoral program IMMUNE PILOT, which introduces medical students to clinical-scientific research at an early stage. The structured program is positioned at the interface of immunology, neuroscience, and genetics and is aimed at students with a strong interest in research who aspire to pursue a career as clinician scientists. The program is funded by the Else Kröner-Fresenius Foundation (EKFS).
View entry
PrepAIred

Honors & Funding

Precise active ingredients against pancreatic cancer

—Pancreatic cancer remains one of the deadliest forms of cancer. At the German Cancer Congress 2026, German Cancer Aid is now presenting three large-scale projects that it is funding as part of its “German Alliance for Pancreatic Cancer” funding priority. In the funded project PrepAIred, Bonn researchers , in cooperation with the University of North Carolina (USA), want to use AI-based protein design to specifically combat pancreatic cancer. German Cancer Aid is funding the project with a total of 1.99 million euros over a period of four years.
View entry

Back to the news overview